TherapeuticsMD (TXMD) Debt Ratio (2010 - 2022)

TherapeuticsMD (TXMD) has reported Debt Ratio for 9 consecutive years, with 0.71 the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Debt Ratio fell 20.06% year-over-year to 0.71; the trailing twelve-month figure through Sep 2022 stood at 0.71 (down 20.06% YoY), and the FY2021 full-year result was 1.11, down 15.12% from the prior year.
• Debt Ratio advanced to 0.71 in Q3 2022 per TXMD's latest filing, from 0.62 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.52 in Q1 2022 and bottomed at 0.31 in Q3 2018.
• Historically, Debt Ratio has averaged 0.84 across 5 years, with a median of 0.79 in 2019.
• The sharpest annual moves came in 2019 and 2021: Debt Ratio jumped 151.28% in 2019, then slumped 33.38% in 2021.
• Over 5 years, Debt Ratio stood at 0.35 in 2018, then jumped by 111.39% to 0.73 in 2019, then surged by 78.86% to 1.31 in 2020, then fell by 15.12% to 1.11 in 2021, then tumbled by 35.9% to 0.71 in 2022.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.71, 0.62, and 1.52 for Q3 2022, Q2 2022, and Q1 2022 respectively.